24 HR Amphetamine aspartate 6.25 MG Amphetamine Sulfate 6.25 MG Dextroamphetamine saccharate 6.25 MG Dextroamphetamine Sulfate 6.25 MG Extended Release Oral Capsule

1 INDICATIONS AND USAGE Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate extended-release Capsules, a CNS stimulant, are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in adults and pediatric patients 6 years and older. ( 1 ) 1.1 attention deficit hyperactivity disorder Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate extended-release capsules are indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in adults and pediatric patients 6 years and older.

amneal pharmaceuticals of new york llc

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] nausea` `[4] pain` `[5] headache` `[6] dyspnoea` `[7] diarrhoea` `[8] vomiting` `[9] off label use` `[10] toxicity to various agents`

5 years ago

CAPSULE BROWN G455

16 HOW SUPPLIED/STORAGE AND HANDLING Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate extended-release capsules (mixed salts of a single-entity amphetamine product), 5 mg are natural bodies and light turquoise blue opaque caps, imprinted with “G451” in black ink on cap. Appearance of contents: beige spherical particles. Bottles of 100.................................................................................................... NDC 0115-1486-01 Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate extended-release capsules (mixed salts of a single-entity amphetamine product), 10 mg are light turquoise blue bodies and light turquoise blue opaque caps, imprinted with “G452” in black ink on cap. Appearance of contents: beige spherical particles. Bottles of 100.................................................................................................... NDC 0115-1487-01 Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate extended-release capsules (mixed salts of a single-entity amphetamine product), 15 mg are light turquoise blue bodies and white opaque caps, imprinted with “G453” in black ink on cap. Appearance of contents: beige spherical particles. Bottles of 100.................................................................................................... NDC 0115-1488-01 Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate extended-release capsules (mixed salts of a single-entity amphetamine product), 20 mg are light brown bodies and light brown opaque caps, imprinted with “G454” in black ink on cap. Appearance of contents: beige spherical particles. Bottles of 100.................................................................................................... NDC 0115-1489-01 Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate extended-release capsules (mixed salts of a single-entity amphetamine product), 25 mg are light brown bodies and white opaque caps, imprinted with “G455” in black ink on cap. Appearance of contents: beige spherical particles. Bottles of 100.................................................................................................... NDC 0115-1490-01 Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate extended-release capsules (mixed salts of a single-entity amphetamine product), 30 mg are natural bodies and light brown opaque caps, imprinted with “G456” in black ink on cap. Appearance of contents: beige spherical particles. Bottles of 100.................................................................................................... NDC 0115-1491-01 Dispense in a tight, light-resistant container as defined in the USP. Store at 20º to 25ºC (68º to 77ºF); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].

More pills like CAPSULE G455

Related Pills

24 HR Amphetamine aspartate 7.5 MG Amphetamine Sulfate 7.5 MG Dextroamphetamine saccharate 7.5 MG Dextroamphetamine Sulfate 7.5 MG Extended Release Oral Capsule

Amneal Pharmaceuticals of New York LLC

24 HR Amphetamine aspartate 3.75 MG Amphetamine Sulfate 3.75 MG Dextroamphetamine saccharate 3.75 MG Dextroamphetamine Sulfate 3.75 MG Extended Release Oral Capsule

Amneal Pharmaceuticals of New York LLC

24 HR Amphetamine aspartate 2.5 MG Amphetamine Sulfate 2.5 MG Dextroamphetamine saccharate 2.5 MG Dextroamphetamine Sulfate 2.5 MG Extended Release Oral Capsule

Amneal Pharmaceuticals of New York LLC

24 HR Amphetamine aspartate 1.25 MG Amphetamine Sulfate 1.25 MG Dextroamphetamine saccharate 1.25 MG Dextroamphetamine Sulfate 1.25 MG Extended Release Oral Capsule

Amneal Pharmaceuticals of New York LLC

24 HR Amphetamine aspartate 5 MG Amphetamine Sulfate 5 MG Dextroamphetamine saccharate 5 MG Dextroamphetamine Sulfate 5 MG Extended Release Oral Capsule

Impax Generics

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site